Glenmark Pharmaceuticals Ltd
NSE: GLENMARK BSE: 532296
₹2504.70
+96.70 (4.02%)
Thu, 12 Nov 2026, 01:40 pm
Market Cap (in Cr)67875.04
PE Ratio39.32
Dividend0.21
Health Technology
Pharmaceuticals: Major
24.5KGlenmark Pharmaceuticals Peer Comparison
Glenmark Pharmaceuticals Ltd
Divis Laboratories Ltd
Laurus Labs Ltd
Zydus Lifesciences Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
| Company Name | Debt to Equity | EV/EBITDA | Industry ROCE % | Industry RONW % | P/B | P/E | ROCE % | ROE % |
|---|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd | 0.16 | 21.55 | 12.29 | 10.69 | 5.73 | 44.20 | 35.07 | 23.56 |
| Torrent Pharmaceuticals Ltd | 1.14 | 35.81 | 14.62 | 13.70 | 17.03 | 66.03 | 18.30 | 26.76 |
| Sun Pharmaceutical Industries Ltd | 0.04 | 22.54 | 12.29 | 10.69 | 5.05 | 36.73 | 18.72 | 14.85 |
| Zydus Lifesciences Ltd | 0.31 | 11.66 | 12.29 | 10.69 | 3.23 | 17.39 | 20.30 | 19.69 |
| Divis Laboratories Ltd | 0 | 39.79 | 14.50 | 12.23 | 9.40 | 61.36 | 21 | 16.19 |
| Laurus Labs Ltd | 0.54 | 30.53 | 12.29 | 10.69 | 10.10 | 60.26 | 16.70 | 18.21 |
